Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled date : 2023 - 01 - 25 save search
Press Release: NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia A
Published: 2023-01-25 (Crawled : 23:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
treatment potential
Macerich Announces Tax Treatment Of 2022 Dividends
Published: 2023-01-25 (Crawled : 22:00) - prnewswire.com
MAC | $15.72 -2.6% 320K
|
Finance
|
| O: 0.54%
H: 1.45%
C: 1.38%
treatment dividends
UMH PROPERTIES, INC. ANNOUNCES TAX TREATMENT FOR 2022 DISTRIBUTIONS
Published: 2023-01-25 (Crawled : 21:00) - globenewswire.com
UMH 4 | $15.615 0.16% 41K
|
Finance
|
| O: 0.24%
H: 0.94%
C: 0.77%
treatment
Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
Published: 2023-01-25 (Crawled : 21:00) - globenewswire.com
ARDS | $0.0635 150K
|
Health Technology
|
| O: -25.2%
H: 2.17%
C: -13.04%
ar-301 treatment trial staphylococcus aureus
Hebrew University' Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023
Published: 2023-01-25 (Crawled : 15:20) - biospace.com/
CMND | $1.19 -1.65% 18K
|
n/a
|
| O: 6.31%
H: 12.35%
C: -7.36%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -0.68%
H: 1.4%
C: 1.4%
treatment obesity biotech
Pulmatrix to Host Key Opinion Leader Webinar "PUR3100 for the Treatment of Acute Migraine: Unlocking the Potential of DHE Treatment"
Published: 2023-01-25 (Crawled : 14:00) - ir.pulmatrix.com
PULM | $2.0201 3.2K
|
Health Technology
|
| O: -2.47%
H: 15.77%
C: 12.96%
pur3100 treatment potential
Vera Therapeutics Hosting a Key Opinion Leader Webinar on Atacicept for the Treatment IgA Nephropathy (IgAN)
Published: 2023-01-25 (Crawled : 13:00) - globenewswire.com
VERA | $38.96 -1.42% 150K
|
Professional, Scientific, and T...
|
| O: -0.33%
H: 1.1%
C: -0.55%
treatment nephropathy therapeutics igan
Eloxx Pharmaceuticals Announces First Patients Enrolled in Phase 2 Clinical Study Evaluating ELX-02 for the Treatment of Alport Syndrome
Published: 2023-01-25 (Crawled : 13:00) - globenewswire.com
ELOX | $0.825 93K
|
Health Technology
|
| O: -0.48%
H: 6.97%
C: 2.64%
elx-02 treatment pharmaceuticals study phase 2
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Italy for the Treatment of Individuals with Multiple System Atrophy
Published: 2023-01-25 (Crawled : 13:00) - biospace.com/
ATHE | $2.39 12.21% 97K
|
Health Technology
|
| O: -2.06%
H: 5.66%
C: 2.63%
ath434 treatment system trial therapeutics phase 2
Lupin Pharma Canada announces the availability of Intrarosa (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy
Published: 2023-01-25 (Crawled : 13:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -3.2%
H: 0.0%
C: 0.0%
treatment pharma women canada
ANNOVIS BIO ANNOUNCES PATIENT ENROLLMENT UPDATE FOR PHASE 3 STUDY OF BUNTANETAP FOR THE TREATMENT OF PARKINSON'S DISEASE
Published: 2023-01-25 (Crawled : 13:00) - prnewswire.com
ANVS | $12.5 5.22% 110K
|
Health Technology
|
| O: 6.62%
H: 0.0%
C: -5.09%
treatment disease parkinson's buntanetap update study
Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
Published: 2023-01-25 (Crawled : 12:00) - globenewswire.com
CDTX | News | $10.89 6.24% 31K
|
Health Technology
|
| O: 15.29%
H: 21.5%
C: 19.63%
treatment fda candidiasis approval therapeutics rezafungin candidemia
Fracking water treatment market size to increase by USD 1,208.4 million: Market research insights highlight the increasing consumption of natural gas as a key driver - Technavio
Published: 2023-01-25 (Crawled : 03:00) - prnewswire.com
XYL | News | $130.11 -0.47% 360K
|
Producer Manufacturing
|
| O: -1.1%
H: 0.59%
C: 0.11%
AQUA | $49.88 0.0% 31M
|
Industrial Services
|
| O: 0.77%
H: 0.0%
C: 0.0%
water treatment research natural market
DIAMONDROCK HOSPITALITY COMPANY ANNOUNCES TAX TREATMENT OF 2022 DIVIDENDS
Published: 2023-01-24 (Crawled : 00:00) - prnewswire.com
DRH | $9.15 710K
|
Finance
|
| O: -0.33%
H: 3.08%
C: 2.75%
treatment dividends
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.